Sustained Release Therapies with the Prostaglandin Analogues Intracameral Implants

Abstract The travoprost intracameral implant was recently approved by the US Food and Drug Administration for sustained release medical treatment of open-angle glaucoma in the USA. The approval represents a substantial and progressive step forward in the area of sustained-release glaucoma therapy. T...

Full description

Bibliographic Details
Published in:Ophthalmology and Therapy
Main Authors: Abdelrahman M. Elhusseiny, Ahmad A. Aref
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-05-01
Subjects:
Travoprost
Implant
Intraocular
IOP
Sustained release
Glaucoma
Online Access:https://doi.org/10.1007/s40123-024-00965-4

Internet

https://doi.org/10.1007/s40123-024-00965-4

Similar Items